Clinical Trial

Assessment of the Impact of Polycystic Ovary Syndrome on Women's Sexuality

Study acronym: SexOPK
Completed
View on ClinicalTrials.gov →
Summary
This study, titled SexOPK, aims to evaluate the impact of polycystic ovary syndrome (PCOS) on women's sexual health. PCOS is a common endocrine disorder affecting 5-20% of women of reproductive age, often leading to hormonal imbalances, metabolic issues, and psychological distress. Despite existing studies on the subject, the level of sexual distress associated with PCOS-related sexual dysfunction remains unclear. The study will compare sexual function and distress levels between women diagnosed with PCOS and a control group without PCOS. Participants will complete an online questionnaire assessing various aspects of sexual health, body image, anxiety, and depression. The findings may help healthcare professionals better understand and address sexual dysfunction in women with PCOS.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-13; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Completed 2026-01-23
Trial Details
NCT Number NCT06887296
Lead Sponsor University Hospital, Toulouse
Conditions Polycystic Ovarian Syndrome (PCOS)
Enrollment 84 participants
Start Date 2025-06-30
Primary Completion 2025-10-24 (estimated)
Study Completion 2025-10-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-26